JAY BARTH, M.D.
Medical Practice at Warwick Ave, Teaneck, NJ

License number
New Jersey MA64725
Category
Medical Practice
Type
Pediatric Gastroenterology
Address
Address
550 Warwick Ave, Teaneck, NJ 07666
Phone
(201) 421-5783

Personal information

See more information about JAY BARTH at radaris.com
Name
Address
Phone
Jay Barth, age 60
550 Warwick Ave, Teaneck, NJ 07666
(201) 862-1904
Jay A Barth, age 61
473 Englewood Ave, Teaneck, NJ 07666
(201) 862-1904
Jay A Barth
473W Englewood Ave, Teaneck, NJ 07666
Jay A Barth, age 60
550 Warwick Ave, Teaneck, NJ 07666
(201) 862-1904

Organization information

See more information about JAY BARTH at bizstanding.com

Jay Barth MD

550 Warwick Ave, Teaneck, NJ 07666

Industry:
Pediatric Gastroenterologist
Phone:
(201) 421-5783 (Phone)
Jay Allan Barth

Professional information

See more information about JAY BARTH at trustoria.com
Jay Barth Photo 1
Dr. Jay Barth, Teaneck NJ - MD (Doctor of Medicine)

Dr. Jay Barth, Teaneck NJ - MD (Doctor of Medicine)

Specialties:
Pediatric Gastroenterology
Address:
550 Warwick Ave, Teaneck 07666
(201) 421-5783 (Phone)
Certifications:
Pediatric Gastroenterology, 2005, Pediatrics, 2000
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Perelman School of Medicine University of Pennsylvania
Graduated: 1989


Jay Barth Photo 2
Novel Methods Using Pyridine Derivatives

Novel Methods Using Pyridine Derivatives

US Patent:
2008023, Sep 25, 2008
Filed:
Jun 19, 2001
Appl. No.:
10/311833
Inventors:
John Ieni - Glen Ridge NJ, US
Jay Barth - Teaneck NJ, US
Robert M. Niecestro - Pocono Pines PA, US
International Classification:
A61K 31/4439, A61P 1/00
US Classification:
514338
Abstract:
The invention provides methods of treating and preventing asthma, laryngitis, symptomatic gastroesophageal reflux disease, pregnancy-induced gastroesophageal reflux disease, noncardiac chest pains, coughing, apnea, dyspepsia, inflammatory bowel disease, irritable bowel syndrome, gastritis, stress ulcers, bleeding peptic ulcers, acute gastrointestinal bleeding, infectious enteritis, collagenous colitis, lymphocytic colitis, chronic diarrhea in immunocompromised patients, esophageal ulcers in immunocompromised patients, idiopathic gastric acid hypersecretion, gastroparesis, gastrointestinal motility disorders, Zollinger-Ellison syndrome, short bowel syndrome, emesis, regurgitation, early satiety, chronic sore throat, abdominal pain, abdominal bloating, nausea, sour stomach, diarrhea, constipation, bacterial infections, refractory ulcers, gastrointestinal disorders induced by NSAIDs, Barrett's esophagus, gastrointestinal disorders caused by steroids, gastrointestinal disorders induced by cholinergic compounds, and fungal or viral-induced ulcers in the gastrointestinal tract by administering a therapeutically effective amount of at least one of the pyridine derivatives of the invention to a patient in need thereof. The invention also provides on demand relief of symptoms associated with gastroesophageal reflux disease (GERD), and provides relief from symptoms caused by the consumption of excessive amounts of food and/or alcohol by administering a therapeutically effective amount of at least one of the pyridine derivatives of the invention to a patient in need thereof. The invention also provides methods for treating parasitic infections, such as malaria, by administering a therapeutically effective amount of at least one of the pyridine derivatives of the invention to a patient in need thereof. In preferred embodiments, the pyridine derivative of the invention is rabeprazole, a pharmaceutically acceptable salt thereof, or a stereoisomer thereof.


Jay Barth Photo 3
Compositions And Methods Using Proton Pump Inhibitors

Compositions And Methods Using Proton Pump Inhibitors

US Patent:
2006002, Feb 2, 2006
Filed:
Nov 16, 2004
Appl. No.:
10/988586
Inventors:
Jay Barth - Teaneck NJ, US
John Ieni - Bloomfield NJ, US
Assignee:
Eisai Co., Ltd. - Tokyo
International Classification:
A61L 9/04, A61K 31/724, A61K 31/4439
US Classification:
424045000, 514338000, 514058000, 424449000
Abstract:
The invention provides methods for treating and preventing gastrointestinal disorders, viral infections, fungal infections, Whipple's disease, sleep disorders, sleep apnea, iron deficiency anemia, asthma, nasal airway resistance, cystic fibrosis, pancreatitis, chemotherapy-induced emesis, radiation-induced injury to the gastrointestinal tract, epilepsy, middle ear infections, obesity, hiatal hernia, anorexia, bulimia, dental decay, post-operative aspiration, migraines and other disorders by administering to a patient a therapeutically effective amount of at least one proton pump inhibitor. In other embodiments, the proton pump inhibitor can be administered with one or more histamine antagonists, antacids, bismuth compounds, anti-viral agents, anti-fungal agents, NSAIDs, steroids, cyclodextrins, cyclodextrin derivatives, and migraine drugs. In other embodiments, the invention provides nasally or transdermally administrable formulations comprising at least one proton pump inhibitor and, optionally, one or more histamine antagonists, antacids, bismuth compounds, anti-viral agents, anti-fungal agents, NSAIDs, steroids, cyclodextrins, cyclodextrin derivatives, and migraine drugs.


Jay Barth Photo 4
Novel Methods Using Aminobenzoic Acid Compounds

Novel Methods Using Aminobenzoic Acid Compounds

US Patent:
2008007, Mar 20, 2008
Filed:
Sep 20, 2007
Appl. No.:
11/902338
Inventors:
Jay Barth - Teaneck NJ, US
Kathleen Lomax - Teaneck NJ, US
Scott Fields - Teaneck NJ, US
Mindell Seidlin - Teaneck NJ, US
Assignee:
EISAI Co., Ltd. - Tokyo
International Classification:
A61K 31/439, A61P 3/04
US Classification:
514305000
Abstract:
The invention provides safe and effective methods for treating and/or preventing gastrointestinal disorders, psychiatric disorders, learning disabilities, Tourette's syndrome, obesity, epilepsy, post-menopausal syndrome, pre-menstrual syndrome, asthma, laryngitis and/or migraines by administering to a patient in need thereof at least one aminobenzoic acid compound. The aminobenzoic acid compound can optionally be administered in combination with other medications that are useful for the disease being treated.


Jay Barth Photo 5
Methods For Treating Methylmalonic Acidemia

Methods For Treating Methylmalonic Acidemia

US Patent:
2012028, Nov 15, 2012
Filed:
Dec 13, 2010
Appl. No.:
13/514324
Inventors:
Jay Allan Barth - Teaneck NJ, US
International Classification:
A61K 31/4245, A61P 3/00, A61K 31/714
US Classification:
514 52, 514364
Abstract:
Methods for treating methylmalonic acidemia in which at least one allele of a gene associated with MMA (e.g., the MUT, MMAA, or MMAB gene) contains a mutation (e.g., nonsense mutation) that results in a premature stop codon in RNA encoded by an allele of the gene associated with MMA involving the administration of a compound that promotes readthrough of RNA (e.g., messenger RNA) containing a premature stop codon encoded by an allele of the gene associated with MMA are described. The compound can be administered as a single-agent therapy or in combination with one or more additional therapies to a human in need of such treatment.


Jay Barth Photo 6
Methods For Preventing And Treating Diseases And Conditions Associated With Cellular Stress

Methods For Preventing And Treating Diseases And Conditions Associated With Cellular Stress

US Patent:
2005003, Feb 10, 2005
Filed:
Jun 7, 2002
Appl. No.:
10/479774
Inventors:
Jay Barth - Teaneck NJ, US
Yoshiaki Goto - Ibaragi, JP
International Classification:
A61K031/12
US Classification:
514675000
Abstract:
This invention relates to methods of preventing and treating diseases and conditions associated with cellular stress. The methods involve administration of an effective amount of a compound of the formula.


Jay Barth Photo 7
Novel Methods Using Aminobenzoic Acid Compounds

Novel Methods Using Aminobenzoic Acid Compounds

US Patent:
2007001, Jan 18, 2007
Filed:
Jan 11, 2006
Appl. No.:
11/332711
Inventors:
Jay Barth - Teaneck NJ, US
Kathleen Lomax - Teaneck NJ, US
Scott Fields - Teaneck NJ, US
Mindell Seidlin - Teaneck NJ, US
International Classification:
A61K 31/46
US Classification:
514304000
Abstract:
The invention provides safe and effective methods for treating and/or preventing gastrointestinal disorders, psychiatric disorders, learning disabilities, Tourette's syndrome, obesity, epilepsy, post-menopausal syndrome, pre-menstrual syndrome, asthma, laryngitis and/or migraines by administering to a patient in need thereof at least one aminobenzoic acid compound. The aminobenzoic acid compound can optionally be administered in combination with other medications that are useful for the disease being treated.